The glomerulus - a view from the outside - the podocyte

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 9, 2010, Pages 1380-1387

  Cheng, Huifang ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired glomerular diseases; Diabetic nephropathy and kidney; Hereditary proteinuria syndrome; Podocyte; Slit diaphragms

Indexed keywords

ALPHA ACTININ 4; CD2 ASSOCIATED PROTEIN; NEPHRIN; PHOSPHODIESTERASE; PHOSPHOLIPASE C EPSILON 1; PODOCIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG; WT1 PROTEIN;

APOPTOSIS; CELL DEDIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CYTOLOGY; GENE MUTATION; GLOMERULOPATHY; GLOMERULUS; HUMAN; NONHUMAN; PODOCYTE; PROTEINURIA; SHORT SURVEY; ANIMAL; BOWMAN CAPSULE; CELL DIFFERENTIATION; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALIA; RODENTIA;

ANIMALS; BOWMAN CAPSULE; CELL DIFFERENTIATION; HUMANS; KIDNEY; KIDNEY GLOMERULUS; PODOCYTES; STEM CELLS;

EID: 77955093872     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.05.014     Document Type: Short Survey

References (134)

1. Akilesh S., Huber T.B., Wu H., Wang G., Hartleben B., Kopp J.B., et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci USA 2008, 105(3):967-972.
2. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20(2):333-343.
3. Arrondel C., Vodovar N., Knebelmann B., Grunfeld J.P., Gubler M.C., Antignac C., et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002, 13(1):65-74.
4. Asanuma K., Campbell K.N., Kim K., Faul C., Mundel P. Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proc Natl Acad Sci USA 2007, 104(24):10134-10139.
5. Asanuma K., Kim K., Oh J., Giardino L., Chabanis S., Faul C., et al. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 2005, 115(5):1188-1198.
6. Asanuma K., Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003, 7(4):255-259.
7. Barbaux S., Niaudet P., Gubler M.C., Grunfeld J.P., Jaubert F., Kuttenn F., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997, 17(4):467-470.
8. Barisoni L., Kriz W., Mundel P., D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999, 10(1):51-61.
9. Barisoni L., Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 2003, 23(5):353-360.
10. Barisoni L., Schnaper H.W., Kopp J.B. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med 2009, 133(2):201-216.
11. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004, 15(6):1382-1391.
12. Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998, 37(3):586-600.
13. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83(11):876-886.
14. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009, 52(11):2251-2263.
15. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000, 24(4):349-354.
16. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic Biol Med 2009.
17. Bussolati B., Bruno S., Grange C., Buttiglieri S., Deregibus M.C., Cantino D., et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005, 166(2):545-555.
18. Chaib H., Hoskins B.E., Ashraf S., Goyal M., Wiggins R.C., Hildebrandt F. Identification of BRAF as a new interactor of PLCepsilon1, the protein mutated in nephrotic syndrome type 3. Am J Physiol Renal Physiol 2008, 294(1):F93-99.
19. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 1998, 19(1):51-55.
20. Cheng H., Wang S., Jo Y.I., Hao C.M., Zhang M., Fan X., et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J Am Soc Nephrol 2007, 18(2):551-559.
21. Chugh S.S. Transcriptional regulation of podocyte disease. Transl Res 2007, 149(5):237-242.
22. Cui T.G., Foster R.R., Saleem M., Mathieson P.W., Gillatt D.A., Bates D.O., et al. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am J Physiol Renal Physiol 2004, 286(4):F767-773.
23. D'Agati V., Yan S.F., Ramasamy R., Schmidt A.M. RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells. Trends Endocrinol Metab 2009.
24. Drenckhahn D., Franke R.P. Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab Invest 1988, 59(5):673-682.
25. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998, 19(1):47-50.
26. Durvasula R.V., Shankland S.J. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 2006, 8(2):132-138.
27. Endlich N., Endlich K. Stretch, tension and adhesion-adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol 2006, 85(3-4):229-234.
28. Eremina V., Baelde H.J., Quaggin S.E. Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007, 106(2):p32-37.
29. Eremina V., Cui S., Gerber H., Ferrara N., Haigh J., Nagy A., et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006, 17(3):724-735.
30. Eremina V., Jefferson J.A., Kowalewska J., Hochster H., Haas M., Weisstuch J., et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358(11):1129-1136.
31. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111(5):707-716.
32. Eyre J., Ioannou K., Grubb B.D., Saleem M.A., Mathieson P.W., Brunskill N.J., et al. Statin-sensitive endocytosis of albumin by glomerular podocytes. Am J Physiol Renal Physiol 2007, 292(2):F674-681.
33. Faul C., Asanuma K., Yanagida-Asanuma E., Kim K., Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007, 17(9):428-437.
34. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9(6):669-676.
35. Garg P., Verma R., Holzman L.B. Slit diaphragm junctional complex and regulation of the cytoskeleton. Nephron Exp Nephrol 2007, 106(2):e67-72.
36. Gbadegesin R., Bartkowiak B., Lavin P.J., Mukerji N., Wu G., Bowling B., et al. Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatr Nephrol 2009, 24(2):281-285.
37. Griffin S.V., Petermann A.T., Durvasula R.V., Shankland S.J. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Nephrol Dial Transplant 2003, 18(Suppl. 6):vi8-13.
38. Gruden G., Perin P.C., Camussi G. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. Curr Diabetes Rev 2005, 1(1):27-40.
39. Guan F., Villegas G., Teichman J., Mundel P., Tufro A. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal Physiol 2006, 291(2):F422-428.
40. Hara M., Yanagihara T., Kihara I. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2007, 2(2):231-238.
41. Hinkes B., Wiggins R.C., Gbadegesin R., Vlangos C.N., Seelow D., Nurnberg G., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006, 38(12):1397-1405.
42. Huber T.B., Benzing T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 2005, 14(3):211-216.
43. Huber T.B., Kwoh C., Wu H., Asanuma K., Godel M., Hartleben B., et al. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 2006, 116(5):1337-1345.
44. Ichikawa I., Ma J., Motojima M., Matsusaka T. Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 2005, 14(3):205-210.
45. Ichimura K., Kurihara H., Sakai T. Actin filament organization of foot processes in rat podocytes. J Histochem Cytochem 2003, 51(12):1589-1600.
46. Inoue T., Yaoita E., Kurihara H., Shimizu F., Sakai T., Kobayashi T., et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001, 59(3):1003-1012.
47. Jalanko H., Patrakka J., Tryggvason K., Holmberg C. Genetic kidney diseases disclose the pathogenesis of proteinuria. Ann Med 2001, 33(8):526-533.
48. Jeanpierre C., Denamur E., Henry I., Cabanis M.O., Luce S., Cecille A., et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 1998, 62(4):824-833.
49. Jho D., Mehta D., Ahmmed G., Gao X.P., Tiruppathi C., Broman M., et al. Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res 2005, 96(12):1282-1290.
50. Jo Y.I., Cheng H., Wang S., Moeckel G.W., Harris R.C. Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes. Nephron Exp Nephrol 2007, 107(3):e87-e94.
51. Kanwar Y.S., Wada J., Sun L., Xie P., Wallner E.I., Chen S., et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008, 233(1):4-11.
52. Kao W.H., Klag M.J., Meoni L.A., Reich D., Berthier-Schaad Y., Li M., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008, 40(10):1185-1192.
53. Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.Q., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24(3):251-256.
54. Kerjaschki D. Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases. Kidney Int 1994, 45(2):300-313.
55. Kestila M., Lenkkeri U., Mannikko M., Lamerdin J., McCready P., Putaala H., et al. Positionally cloned gene for a novel glomerular protein--nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1(4):575-582.
56. Kim J.M., Wu H., Green G., Winkler C.A., Kopp J.B., Miner J.H., et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003, 300(5623):1298-1300.
57. Koop K., Eikmans M., Baelde H.J., Kawachi H., De Heer E., Paul L.C., et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003, 14(8):2063-2071.
58. Kos C.H., Le T.C., Sinha S., Henderson J.M., Kim S.H., Sugimoto H., et al. Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest 2003, 111(11):1683-1690.
59. Kreidberg J.A. Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 2003, 14(3):806-814.
60. Kriz W. Progression of chronic renal failure in focal segmental glomerulosclerosis: consequence of podocyte damage or of tubulointerstitial fibrosis?. Pediatr Nephrol 2003, 18(7):617-622.
61. Kriz W., Gretz N., Lemley K.V. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int 1998, 54(3):687-697.
62. Kurihara H., Anderson J.M., Farquhar M.G. Diversity among tight junctions in rat kidney: glomerular slit diaphragms and endothelial junctions express only one isoform of the tight junction protein ZO-1. Proc Natl Acad Sci USA 1992, 89(15):7075-7079.
63. Lai K.N., Leung J.C., Chan L.Y., Saleem M.A., Mathieson P.W., Tam K.Y., et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 2009, 24(1):62-72.
64. Lee H.S., Song C.Y. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease. Histol Histopathol 2009, 24(7):901-908.
65. Lemley K.V., Lafayette R.A., Safai M., Derby G., Blouch K., Squarer A., et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002, 61(4):1475-1485.
66. Little M.H., Bertram J.F. Is there such a thing as a renal stem cell?. J Am Soc Nephrol 2009, 20(10):2112-2117.
67. Lowik M.M., Groenen P.J., Levtchenko E.N., Monnens L.A., van den Heuvel L.P. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis-a review. Eur J Pediatr 2009, 168(11):1291-1304.
68. Lu T.C., He J.C., Klotman P.E. Podocytes in HIV-associated nephropathy. Nephron Clin Pract 2007, 106(2):c67-71.
69. Machuca E., Benoit G., Antignac C. Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet 2009, 18(R2):R185-R194.
70. Marshall C.B., Shankland S.J. Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 2005, 102(2):e39-e48.
71. Marshall S.M. The podocyte: a major player in the development of diabetic nephropathy?. Horm Metab Res 2005, 37(Suppl. 1):9-16.
72. Marshall S.M. The podocyte: a potential therapeutic target in diabetic nephropathy?. Curr Pharm Des 2007, 13(26):2713-2720.
73. Mathieson P.W. Update on the podocyte. Curr Opin Nephrol Hypertens 2009, 18(3):206-211.
74. McIntosh I., Dreyer S.D., Clough M.V., Dunston J.A., Eyaid W., Roig C.M., et al. Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet 1998, 63(6):1651-1658.
75. Michaud J.L., Lemieux L.I., Dube M., Vanderhyden B.C., Robertson S.J., Kennedy C.R. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 2003, 14(5):1200-1211.
76. Miner J.H. Glomerular filtration: the charge debate charges ahead. Kidney Int 2008, 74(3):259-261.
77. Moller C.C., Pollak M.R., Reiser J. The genetic basis of human glomerular disease. Adv Chronic Kidney Dis 2006, 13(2):166-173.
78. Montell C. The TRP superfamily of cation channels. Sci STKE 2005, 2005(272):re3.
79. Morello R., Lee B. Insight into podocyte differentiation from the study of human genetic disease: nail-patella syndrome and transcriptional regulation in podocytes. Pediatr Res 2002, 51(5):551-558.
80. Mundel P., Kriz W. Structure and function of podocytes: an update. Anat Embryol (Berl) 1995, 192(5):385-397.
81. Mundel P., Reiser J., Kriz W. Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 1997, 8(5):697-705.
82. Mundel P., Reiser J., Zuniga Mejia Borja A., Pavenstadt H., Davidson G.R., Kriz W., et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997, 236(1):248-258.
83. Mundel P., Shankland S.J. Podocyte biology and response to injury. J Am Soc Nephrol 2002, 13(12):3005-3015.
84. Nagata M., Tomari S., Kanemoto K., Usui J., Lemley K.V. Podocytes, parietal cells, and glomerular pathology: the role of cell cycle proteins. Pediatr Nephrol 2003, 18(1):3-8.
85. Neal C.R., Crook H., Bell E., Harper S.J., Bates D.O. Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J Am Soc Nephrol 2005, 16(5):1223-1235.
86. Neal C.R., Muston P.R., Njegovan D., Verrill R., Harper S.J., Deen W.M., et al. Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditions. Am J Physiol Renal Physiol 2007, 293(6):F1787-1798.
87. Ng W.L., Chan K.W., Yeung C.K., Kwan S. Peripheral glomerular capillary wall lesions in IgA nephropathy and their implications. Pathology 1984, 16(3):324-330.
88. Niranjan T., Murea M., Susztak K. The pathogenic role of notch activation in podocytes. Nephron Exp Nephrol 2009, 111(4):e73-79.
89. Okamoto T., Yamagishi S., Inagaki Y., Amano S., Koga K., Abe R., et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002, 16(14):1928-1930.
90. Orloff M.S., Iyengar S.K., Winkler C.A., Goddard K.A., Dart R.A., Ahuja T.S., et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 2005, 21(2):212-221.
91. Papeta N., Chan K.T., Prakash S., Martino J., Kiryluk K., Ballard D., et al. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest 2009, 119(5):1178-1188.
92. Parast M.M., Otey C.A. Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol 2000, 150(3):643-656.
93. Pavenstadt H. Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol 2000, 278(2):F173-179.
94. Pippin J.W., Brinkkoetter P.T., Cormack-Aboud F.C., Durvasula R.V., Hauser P.V., Kowalewska J., et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 2009, 296(2):F213-229.
95. Quaggin S.E., Kreidberg J.A. Development of the renal glomerulus: good neighbors and good fences. Development 2008, 135(4):609-620.
96. Ramasamy R., Yan S.F., Schmidt A.M. RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J Leukoc Biol 2009, 86(3):505-512.
97. Ramsey I.S., Delling M., Clapham D.E. An introduction to TRP channels. Annu Rev Physiol 2006, 68:619-647.
98. Reiser J., Kriz W., Kretzler M., Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000, 11(1):1-8.
99. Reiser J., Polu K.R., Moller C.C., Kenlan P., Altintas M.M., Wei C., et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005, 37(7):739-744.
100. Rohr C., Prestel J., Heidet L., Hosser H., Kriz W., Johnson R.L., et al. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Invest 2002, 109(8):1073-1082.
101. Ronconi E., Sagrinati C., Angelotti M.L., Lazzeri E., Mazzinghi B., Ballerini L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009, 20(2):322-332.
102. Rosenstiel P., Gharavi A., D'Agati V., Klotman P. Transgenic and infectious animal models of HIV-associated nephropathy. J Am Soc Nephrol 2009, 20(11):2296-2304.
103. Rostgaard J., Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 1997, 53(1):1-13.
104. Sagrinati C., Netti G.S., Mazzinghi B., Lazzeri E., Liotta F., Frosali F., et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006, 17(9):2443-2456.
105. Saleem M.A., O'Hare M.J., Reiser J., Coward R.J., Inward C.D., Farren T., et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002, 13(3):630-638.
106. Salmon A.H., Neal C.R., Harper S.J. New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr Opin Nephrol Hypertens 2009, 18(3):197-205.
107. Sato U., Kitanaka S., Sekine T., Takahashi S., Ashida A., Igarashi T. Functional characterization of LMX1B mutations associated with nail-patella syndrome. Pediatr Res 2005, 57(6):783-788.
108. Sayyed S.G., Hagele H., Kulkarni O.P., Endlich K., Segerer S., Eulberg D., et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009, 52(11):2445-2454.
109. Schiffer M., Bitzer M., Roberts I.S., Kopp J.B., ten Dijke P., Mundel P., et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001, 108(6):807-816.
110. Schlondorff J.S., Pollak M.R. TRPC6 in glomerular health and disease: what we know and what we believe. Semin Cell Dev Biol 2006, 17(6):667-674.
111. Seri M., Cusano R., Gangarossa S., Caridi G., Bordo D., Lo Nigro C., et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 2000, 26(1):103-105.
112. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006, 69(12):2131-2147.
113. Shankland S.J., Pippin J.W., Reiser J., Mundel P. Podocytes in culture: past, present, and future. Kidney Int 2007, 72(1):26-36.
114. Shih N.Y., Li J., Karpitskii V., Nguyen A., Dustin M.L., Kanagawa O., et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286(5438):312-315.
115. Shirato I. Podocyte process effacement in vivo. Microsc Res Technol 2002, 57(4):241-246.
116. Shirato I., Sakai T., Kimura K., Tomino Y., Kriz W. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. Am J Pathol 1996, 148(4):1283-1296.
117. Simons M., Hartleben B., Huber T.B. Podocyte polarity signalling. Curr Opin Nephrol Hypertens 2009, 18(4):324-330.
118. Srichai M.B., Konieczkowski M., Padiyar A., Konieczkowski D.J., Mukherjee A., Hayden P.S., et al. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 2004, 279(14):14398-14408.
119. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003, 278(15):12605-12608.
120. Sung S.H., Ziyadeh F.N., Wang A., Pyagay P.E., Kanwar Y.S., Chen S. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006, 17(11):3093-3104.
121. Takeda T., McQuistan T., Orlando R.A., Farquhar M.G. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001, 108(2):289-301.
122. Tan A.L., Forbes J.M., Cooper M.E. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007, 27(2):130-143.
123. Tanji N., Markowitz G.S., Fu C., Kislinger T., Taguchi A., Pischetsrieder M., et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000, 11(9):1656-1666.
124. Tesch G.H. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008, 294(4):F697-701.
125. Thomas D.B. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med 2009, 133(2):217-223.
126. 2+ signaling in the regulation of endothelial permeability. Vascul Pharmacol 2002, 39(4-5):173-185.
127. Tryggvason K., Patrakka J., Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006, 354(13):1387-1401.
128. Velez J.C., Bland A.M., Arthur J.M., Raymond J.R., Janech M.G. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007, 293(1):F398-407.
129. Vollrath D., Jaramillo-Babb V.L., Clough M.V., McIntosh I., Scott K.M., Lichter P.R., et al. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum Mol Genet 1998, 7(7):1091-1098.
130. Wendt T.M., Tanji N., Guo J., Kislinger T.R., Qu W., Lu Y., et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003, 162(4):1123-1137.
131. Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005, 308(5729):1801-1804.
132. Wolf G., Stahl R.A. CD2-associated protein and glomerular disease. Lancet 2003, 362(9397):1746-1748.
133. Xu Z.G., Ryu D.R., Yoo T.H., Jung D.S., Kim J.J., Kim H.J., et al. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. Nephrol Dial Transplant 2005, 20(3):524-531.
134. Zheng Z., Schmidt-Ott K.M., Chua S., Foster K.A., Frankel R.Z., Pavlidis P., et al. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci USA 2005, 102(7):2502-2507.